Kaizen Financial Strategies

Position in AMGN — Amgen Inc

CIK 1842013 CAMPBELL, CA

Position in AMGN

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$504,433

+$17,473 QoQ

Shares Held

1,393

+0.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.46%

of 13F equity value

Holder Rank

#2,175

of 3,140 holders

Holding Since

Dec 2020

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Kaizen Financial Strategies holds $4,120,314 across 6 Drug Manufacturers - General names. AMGN ranks #3 (12.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,464	$1,755,965
2	ABBV	AbbVie Inc.	4,092	$1,029,710
3	AMGN	Amgen Inc This page	1,393	$504,433
4	GILD	Gilead Sciences, Inc.	2,784	$351,730
5	MRK	Merck & Co., Inc.	2,010	$258,285
6	JNJ	Johnson & Johnson	867	$220,191

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$504,433	1,393	+0.7%	Shares	Sole	2026-07-30
2026-03-31	$486,960	1,384	+1.1%	Shares	Sole	2026-05-01
2025-12-31	$448,087	1,369	+0.7%	Shares	Sole	2026-01-21
2025-09-30	$383,792	1,360	-19.1%	Shares	Sole	2025-11-12
2025-06-30	$469,631	1,682	+7.5%	Shares	Sole	2025-08-08
2025-03-31	$487,575	1,565	+0.8%	Shares	Sole	2025-04-09
2024-12-31	$404,773	1,553	+35.9%	Shares	Sole	2025-02-14
2024-09-30	$368,286	1,143	-3.1%	Shares	Sole	2024-11-04
2024-06-30	$368,378	1,179	-3.8%	Shares	Sole	2024-08-05
2024-03-31	$348,292	1,225	+5.2%	Shares	Sole	2024-05-03
2023-12-31	$335,543	1,165	+0.5%	Shares	Sole	2024-01-18
2023-09-30	$311,492	1,159	+0.8%	Shares	Sole	2023-10-31
2023-06-30	$255,323	1,150	+0.8%	Shares	Sole	2023-08-08
2023-03-31	$275,836	1,141	+0.5%	Shares	Sole	2023-05-11
2020-12-31	$260,959	1,135	—	Shares	Sole	2021-02-03
No filing history on record for this holder in this stock.